premenstrual%20dysphoric%20disorder
PREMENSTRUAL DYSPHORIC DISORDER
Premenstrual dysphoric disorder is a cyclical disorder presenting with distressing mood and behavioral symptoms that occur during the late luteal phase of the ovulatory cycle; it is a severe form of premenstrual syndrome.
It results in considerable impairment of the patient's personal functioning that occurs in approximately 5% of women of reproductive age.

Premenstrual%20dysphoric%20disorder Signs and Symptoms

Introduction

Premenstrual Syndrome (PMS)

  • PMS is a group of recurrent mild to moderate physical and/or emotional symptoms occurring during the late luteal phase of the ovulatory cycle that do not usually interfere with the patient’s usual level of function
    • Occurs in approximately 75% of women of reproductive age, among whom 20-50% report moderate to severe symptoms

Definition

Premenstrual Dysphoric Disorder (PMDD)

  • PMDD is a cyclical disorder presenting with distressing mood and behavioral symptoms that occur during the late luteal phase of the ovulatory cycle; it is a severe form of PMS
  • PMDD results in considerable impairment of the patient’s personal functioning
    • Occurs in approximately 5% of women of reproductive age

Underlying Medical and Psychiatric Disorders

The following medical conditions may mimic PMDD with premenstrual exacerbation:
  • Allergies
  • Anemia
  • Asthma
  • Autoimmune or collagen vascular disorders
  • Chronic fatigue syndrome
  • Endometriosis
  • Endocrine disorders [diabetes mellitus (DM), hypothyroidism]
  • Epilepsy
  • Hyperprolactinemia
  • Irritable bowel syndrome
  • Migraine
  • Panhypopituitarism
  • Polycystic ovarian disease

The following psychiatric conditions may mimic PMDD with premenstrual exacerbation:

  • Anxiety disorders
  • Bipolar disorder
  • Bulimia
  • Cyclothymic disorder
  • Depression
  • Dysthymic disorder
  • Posttraumatic stress disorder
  • Psychosocial (current victim of physical abuse or history of sexual abuse)
  • Panic disorder
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Psychiatry - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Stephen Padilla, 29 Sep 2020
The coronavirus disease (COVID-19) pandemic appears to have quickened the acceptance of prescription digital therapeutics (PDT), or software that helps treat human disease, by clinicians and patients, particularly those suffering from mental health conditions, according to experts from one of the sessions at the 2020 Virtual Forum of the Asia Pacific Medical Technology Association (APACMed 2020).